Particle.news

Download on the App Store

Serena Williams Says GLP-1 Treatment Helped Her Shed 31 Pounds, Joins Ro Campaign

She frames the medication as healthcare after years of postpartum weight struggles.

Image
Image
Image
Image

Overview

  • Williams confirms using a GLP-1 medication, saying she became consistent with weekly injections in April after starting intermittently following the end of breastfeeding in early 2024.
  • She reports improved blood sugar readings, reduced knee and joint pain, and higher energy, and says she has not experienced side effects.
  • The 23-time Grand Slam champion has signed on as a paid ambassador for telehealth firm Ro in a multi-year effort to normalize weight-loss treatment.
  • Ro discloses that Williams’ husband, Alexis Ohanian, is an investor and serves on its board, a connection highlighted alongside the campaign.
  • Williams has not publicly named the specific drug; most outlets report it is unspecified as one report attributes Zepbound, a claim not widely corroborated.